Median follow-up post-HBIG discontinuation was 40 (range, 5-51) months.

在停用HBIG后平均随访40个月（范围为5-51个月）。

HBIG was discontinued a median of 26 (range, 0.2-121) months after OLT.

在原位肝移植术后平均26(范围0.2 - 121个月)个月HBIG被停用。

Conclusion HBIG before laboring can decrease the HBV intrauterine infection rate.

结论产前应用hbig可降低HBV宫内感染率。

Probability of HBV recurrence was 0% and 9% at 2 and 4 years after HBIG discontinuation.

停用HBIG后第二年和第四年的乙肝复发概率分别为0%和9%。

CONCLUSIONS: The HBV intrauterine infection could be decreased by using HBIG during pregnancy.

结论：产前应用hbig可降低乙肝病毒宫内感染率。